COMBINATION CHEMOTHERAPY OF OVARIAN-CARCINOMA WITH CISPLATINUM AND TREOSULFAN - A PHASE-II STUDY

被引：16

作者：

DUNCAN, ID

CLAYTON, LA

机构：

来源：

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 1985年 / 92卷 / 07期

关键词：

D O I：

10.1111/j.1471-0528.1985.tb01462.x

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：762 / 767

页数：6

共 18 条

[1] ABDULLAH U, 1983, 13TH P INT C CHEM VI
[2] BARKER GH, 1981, LANCET, V1, P747
[3] DROBNIK J, 1983, CANCER CHEMOTH PHARM, V10, P145
[4] ERLICH CE, 1983, CLIN OBSTET GYNAECOL, V10, P325
[5] STUDIES ON EPOXIDE FORMATION FROM (2S,3S)-THREITOL 1,4-BISMETHANESULFONATE - PREPARATION AND BIOLOGICAL ACTIVITY OF (2S,3S)-1,2-EPOXY-3,4-BUTANEDIOL 4-METHANESULFONATE
FEIT, PW
RASTRUPA.N
MATAGNE, R
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1970, 13 (06) : 1173 - &
[6] TREOSULFAN (DIHYDROXYBUSULFAN) IN MANAGEMENT OF OVARIAN CARCINOMA
FENNELLY, J
[J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1977, 84 (04): : 300 - 303
[7] FENNELLY JJ, 1983, 13TH P INT C CHEM VI
[8] LARSEN MS, 1973, ACTA OBSTET GYNAEC S, V22, P12
[9] LUNDVALL F, 1973, ACTA OBSTET GYNECO S, V22, P3
[10] NADIAS EN, 1978, AM J MED, V65, P307